Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators research question is whether or not yoga effectively alleviates symptoms of pain, sleep disturbance, anxiety and depression in children with cystic fibrosis. If yoga does prove to be effective, the investigators will educate our CF population about the benefits they may experience if they choose to incorporate yoga into their CF therapy. The investigators will also go on to do further research of other complementary alternative medicine therapies.
This is a pre/post-test study with 20 subjects. The subjects will serve as their own controls. Each subject will participate in six yoga sessions over a ten week period. Subjects' symptoms will be evaluated with the use of questionnaires. The investigators will also test cortisol levels on weeks -2, -1, 1, 6, 7, 8. Cortisol is a hormone that is affected by stress. Testing of cortisol throughout the study will help us determine the subjects' stress level throughout the study.
H1: The implementation of a yoga therapy program decreases symptoms of pain within our CF population.
H2: The implementation of a yoga therapy program decreases symptoms of sleep disturbance within our CF population.
H3: The implementation of a yoga therapy program decreases symptoms of anxiety within our CF population.
H4: The implementation of a yoga therapy program decreases symptoms of depression within our CF population.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Alternative Treatment | Other | The CF Patient Population receiving the specific yoga study treatment |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Yoga treatment program | Other | yoga program designed specifically for the patient with CF |
|
| Measure | Description | Time Frame |
|---|---|---|
| Improve Quality of Life measured through self report questionnaires | Tool: CFQ-R | We expect this study to last one year. |
| Measure | Description | Time Frame |
|---|---|---|
| Reduce symptoms of pain measured through self report questionnaires | Tools: 1) MSAS and 2)Additional Pain Symptoms Questions | 1 year |
| Reduce symptoms of anxiety measured through self report questionnaires and cortisol testing |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| John McNamara, MD | Children's Hospitals and Clinics of Minnesota | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Children's Hospitals and Clinics of Minnesota | Minneapolis | Minnesota | 55404 | United States |
Not provided
| ID | Term |
|---|---|
| D003550 | Cystic Fibrosis |
| ID | Term |
|---|---|
| D010182 | Pancreatic Diseases |
| D004066 | Digestive System Diseases |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Assessed through 1)Saliva cortisol testing and 2)tools:STAIC and HADS
| 1 year |
| Reduce symptoms of sleep disturbance measured through self report questionnaires | tools: 1)MSAS and 2)CES-DC | 1 year |
| Reduce symptoms of depression measured through self report questionnaires and cortisol testing | tools: 1)CES-DC, 2) HADS and 3) saliva cortisol testing | 1 year |
| D030342 |
| Genetic Diseases, Inborn |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D007232 | Infant, Newborn, Diseases |